Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid TumorDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Syndactyly, Type I, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pancreatic ductal adenocarcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 1 / Phase 22025-07-30NCT06105021

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Affini-T Therapeutics, Inc.2

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Fred Hutchinson Cancer CenterSeattleUnited States250
Laura & Isaac Perlmutter Cancer Center at NYU Langone HealthNew YorkUnited States27
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Providence Cancer Institute Franz ClinicPortlandUnited States25
Sarah Cannon Research InstituteNashvilleUnited States119
University of California Los Angeles Department of MedicineLos AngelesUnited States1
University of Wisconsin Carbone Cancer CenterMadisonUnited States58
USC Norris ComprehensiveLos AngelesUnited States1
Yale New Haven HospitalNew HavenUnited States8